Kelsey Dawes

Kelsey Dawes has a wealth of experience in the field. From 2017-2019, they were a Research Associate at the University of Iowa Health Care. Kelsey then moved on to be a Graduate Student Researcher at the University of Iowa from 2019-2022. During this time, they also held a Molecular Diagnostic Intern role at Behavioral Diagnostics LLC. In 2022, they became a Research Scientist- Translational Epigenetics at the University of Iowa Roy J. and Lucille A. Carver College of Medicine, and is currently the Founder & CEO of Relevant Methylomics Inc.

Kelsey Dawes has a Doctor of Philosophy (PhD) in Molecular Medicine from the University of Iowa, which they obtained from 2019 to 2022. Prior to that, they earned a Bachelor's degree in Interdepartmental Studies: Health Studies from the University of Iowa from 2015 to 2017.